These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. A controlled trial of renal denervation for resistant hypertension. Bhatt DL; Kandzari DE; O'Neill WW; D'Agostino R; Flack JM; Katzen BT; Leon MB; Liu M; Mauri L; Negoita M; Cohen SA; Oparil S; Rocha-Singh K; Townsend RR; Bakris GL; N Engl J Med; 2014 Apr; 370(15):1393-401. PubMed ID: 24678939 [TBL] [Abstract][Full Text] [Related]
14. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension. Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240 [TBL] [Abstract][Full Text] [Related]
15. Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design. Böhm M; Townsend RR; Kario K; Kandzari D; Mahfoud F; Weber MA; Schmieder RE; Tsioufis K; Hickey GL; Fahy M; DeBruin V; Brar S; Pocock S Clin Res Cardiol; 2020 Mar; 109(3):289-302. PubMed ID: 32034481 [TBL] [Abstract][Full Text] [Related]
16. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Azizi M; Sharp ASP; Fisher NDL; Weber MA; Lobo MD; Daemen J; Lurz P; Mahfoud F; Schmieder RE; Basile J; Bloch MJ; Saxena M; Wang Y; Sanghvi K; Jenkins JS; Devireddy C; Rader F; Gosse P; Claude L; Augustin DA; McClure CK; Kirtane AJ; Circulation; 2024 Mar; 149(10):747-759. PubMed ID: 37883784 [TBL] [Abstract][Full Text] [Related]
17. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL; J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443 [TBL] [Abstract][Full Text] [Related]
18. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL; J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423 [TBL] [Abstract][Full Text] [Related]
19. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED. Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554 [TBL] [Abstract][Full Text] [Related]
20. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]